Renal Failure
📧 Sign up to get email alerts when something new happens for Renal Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-09-22Clinical Trial Update: Influence of Variable Inflow Volume, Dwell Duration and Glucose Concentration on Ultrafiltration Volume in APD Patients [NA]
A clinical trial examining how inflow volume, dwell duration, and glucose concentration affect ultrafiltration volume in automated peritonea…
-
CLINICAL_TRIALS withdrawal · 2025-01-30Clinical Trial Update: A Study of Sleeve Gastrectomy Risks and Benefits
A Mayo Clinic-sponsored study evaluating the risks and benefits of sleeve gastrectomy for renal failure has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-11-03Clinical Trial Update: Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two Drugs [Phase 3]
A Phase 3 trial comparing two pancreatic enzyme drugs in patients with pancreatic insufficiency has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-02-08Clinical Trial Update: Rifaximin Versus Lactulose in Renal Failure [Phase 4]
Phase 4 trial comparing rifaximin to lactulose in patients with liver cirrhosis and renal failure was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-02-15Clinical Trial Update: Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure [Phase 2]
A Phase 2 trial evaluating whether midodrine, octreotide, and albumin can improve renal function in patients with liver cirrhosis and renal …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-12-20Clinical Trial Update: Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant [Phase 4]
A Phase 4 trial evaluating direct-acting antiviral therapy to prevent HCV infection in HCV-positive donor to HCV-negative recipient kidney t…
-
CLINICAL_TRIALS withdrawal · 2018-03-20Clinical Trial Update: Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients [Phase 4]
Phase 4 pharmacokinetic study of ceftazidime in intermittent hemodialysis patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-21Clinical Trial Update: Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Renal Failure [NA]
The trial evaluating autologous adipose-derived stromal cells in patients with renal failure has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-10Clinical Trial Update: Study of the Effect on Clinical Outcomes Using Secure Text Messaging [NA]
The University of Pennsylvania-sponsored trial NCT02568514 evaluating the effect of secure text messaging on clinical outcomes has been with…